Skip to main content

Hypothetical Concerns

I was greatly heartened by David Horrobin's article "Discouraging Hypotheses Slows Progress" [The Scientist, Nov. 26, 1990, page 13]. For 10 years I have been attempting to publish what amounts to a unified hypothesis of the evolutionary development of intermediary metabolic cell growth control and, in particular, how it relates to cellular differentiation and cancer cell growth. Of course, a full testing of the hypothesis would be nothing short of a Manhattan Project-sized undertaking. However

Written byGregory Bambeck
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Although I graduated at the top of my class, and in the top 1 percent worldwide, this inability to publish a unifying theory has not only had detrimental consequences on my career, but also casts serious aspersions upon both the recognized scientific leadership and the hierarchical bureaucratic publication mechanism in the medical, biomolecular, and allied sciences. It is nothing short of ethical scientific crime when United States patents can be granted, based upon a theory that can't even be published. How much "proof in the pudding" is required to couple theory and application to publication?

I find Horrobin's efforts to be laudable and downright heroic. We theoreticians tire of receiving blanket rejections by publication staff members who do not even permit our work to be submitted to the review process. There is nothing more demeaning to a qualified professional than to be rejected from peer review consideration by the publication ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays